Cargando…
Bisphosphonates and glucocorticoid-induced osteoporosis: cons
During the use of glucocorticoids (GCs), both vertebral and nonvertebral fracture risk are increased, due to the direct and indirect negative effects of GCs on bone, muscles, and the activity of the underlying inflammatory diseases. Inhibition of bone formation and increased apoptosis of osteocytes...
Autores principales: | Lems, Willem F., Saag, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512570/ https://www.ncbi.nlm.nih.gov/pubmed/26041376 http://dx.doi.org/10.1007/s12020-015-0639-1 |
Ejemplares similares
-
2022 - Pros and Cons in General Internal Medicine and Geriatrics
por: Cucinotta, Domenico
Publicado: (2023) -
2021- Pros and Cons in General Internal Medicine and Geriatrics
por: Cucinotta, Domenico
Publicado: (2022) -
Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011) -
Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
por: Raterman, Hennie G., et al.
Publicado: (2019) -
Glucocorticoid-induced osteoporosis: from clinical trials to clinical
practice
por: Adami, Giovanni, et al.
Publicado: (2019)